424 research outputs found
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
Herpes simplex virus type 2 (HSV-2) infection causes significant disease globally. Adolescent and adult infection may present as painful genital ulcers. Neonatal infection has high morbidity and mortality. Additionally, HSV-2 likely contributes substantially to the spread of HIV infection. The global burden of HSV-2 infection was last estimated for 2003. Here we present new global estimates for 2012 of the burden of prevalent (existing) and incident (new) HSV-2 infection among females and males aged 15-49 years, using updated methodology to adjust for test performance and estimate by World Health Organization (WHO) region.We conducted a literature review of HSV-2 prevalence studies world-wide since 2000. We then fitted a model with constant HSV-2 incidence by age to pooled HSV-2 prevalence values by age and sex. Prevalence values were adjusted for test sensitivity and specificity. The model estimated prevalence and incidence by sex for each WHO region to obtain global burden estimates. Uncertainty bounds were computed by refitting the model to reflect the variation in the underlying prevalence data. In 2012, we estimate that there were 417 million people aged 15-49 years (range: 274-678 million) living with HSV-2 infection world-wide (11.3% global prevalence), of whom 267 million were women. We also estimate that in 2012, 19.2 million (range: 13.0-28.6 million) individuals aged 15-49 years were newly-infected (0.5% of all individuals globally). The highest burden was in Africa. However, despite lower prevalence, South-East Asia and Western Pacific regions also contributed large numbers to the global totals because of large population sizes.The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, microbicides, and other new HSV prevention strategies
First estimates of the global and regional incidence of neonatal herpes infection
Background Neonatal herpes is a rare but potentially devastating condition with an estimated 60% fatality rate without
treatment. Transmission usually occurs during delivery from mothers with herpes simplex virus type 1 (HSV-1) or
type 2 (HSV-2) genital infection. However, the global burden has never been quantifi ed to our knowledge. We
developed a novel methodology for burden estimation and present fi rst WHO global and regional estimates of the
annual number of neonatal herpes cases during 2010–15.
Methods We applied previous estimates of HSV-1 and HSV-2 prevalence and incidence in women aged 15–49 years to
2010–15 birth rates to estimate infections during pregnancy. We then applied published risks of neonatal HSV
transmission according to whether maternal infection was incident or prevalent with HSV-1 or HSV-2 to generate
annual numbers of incident neonatal infections. We estimated the number of incident neonatal infections by
maternal age, and we generated separate estimates for each WHO region, which were then summed to obtain global
estimates of the number of neonatal herpes infections.
Findings Globally the overall rate of neonatal herpes was estimated to be about ten cases per 100 000 livebirths,
equivalent to a best-estimate of 14 000 cases annually roughly (4000 for HSV-1; 10 000 for HSV-2). We estimated that
the most neonatal herpes cases occurred in Africa, due to high maternal HSV-2 infection and high birth rates. HSV-1
contributed more cases than HSV-2 in the Americas, Europe, and Western Pacifi c. High rates of genital HSV-1
infection and moderate HSV-2 prevalence meant the Americas had the highest overall rate. However, our estimates
are highly sensitive to the core assumptions, and considerable uncertainty exists for many settings given sparse
underlying data.
Interpretation These neonatal herpes estimates mark the fi rst attempt to quantify the global burden of this rare but
serious condition. Better collection of primary data for neonatal herpes is crucially needed to reduce uncertainty and
refi ne future estimates. These data are particularly important in resource-poor settings where we may have
underestimated cases. Nevertheless, these fi rst estimates suggest development of new HSV prevention measures
such as vaccines could have additional benefi ts beyond reducing genital ulcer disease and HSV-associated HIV
transmission, through prevention of neonatal herpes
Recommended from our members
Variable responses of human and non-human primate gut microbiomes to a Western diet
BACKGROUND: The human gut microbiota interacts closely with human diet and physiology. To better understand the mechanisms behind this relationship, gut microbiome research relies on complementing human studies with manipulations of animal models, including non-human primates. However, due to unique aspects of human diet and physiology, it is likely that host-gut microbe interactions operate differently in humans and non-human primates. RESULTS: Here, we show that the human microbiome reacts differently to a high-protein, high-fat Western diet than that of a model primate, the African green monkey, or vervet (Chlorocebus aethiops sabaeus). Specifically, humans exhibit increased relative abundance of Firmicutes and reduced relative abundance of Prevotella on a Western diet while vervets show the opposite pattern. Predictive metagenomics demonstrate an increased relative abundance of genes associated with carbohydrate metabolism in the microbiome of only humans consuming a Western diet. CONCLUSIONS: These results suggest that the human gut microbiota has unique properties that are a result of changes in human diet and physiology across evolution or that may have contributed to the evolution of human physiology. Therefore, the role of animal models for understanding the relationship between the human gut microbiota and host metabolism must be re-focused.P40 OD010965 - NIH HHS; P40 RR019963 - NCRR NIH HHS; P51 OD011132 - NIH HHS; R01 RR016300 - NCRR NIH HHS; 5R01RR016300 - NCRR NIH HH
A Structural Atlas of the Developing Zebrafish Telencephalon Based on Spatially-Restricted Transgene Expression
Zebrafish telencephalon acquires an everted morphology by a two-step process that occurs from 1 to 5 days post-fertilization (dpf). Little is known about how this process affects the positioning of discrete telencephalic cell populations, hindering our understanding of how eversion impacts telencephalic structural organization. In this study, we characterize the neurochemistry, cycle state and morphology of an EGFP positive (+) cell population in the telencephalon of Et(gata2:EGFP)bi105 transgenic fish during eversion and up to 20dpf. We map the transgene insertion to the early-growth-response-gene-3 (egr3) locus and show that EGFP expression recapitulates endogenous egr3 expression throughout much of the pallial telencephalon. Using the gata2:EGFP bi105 transgene, in combination with other well-characterized transgenes and structural markers, we track the development of various cell populations in the zebrafish telencephalon as it undergoes the morphological changes underlying eversion. These datasets were registered to reference brains to form an atlas of telencephalic development at key stages of the eversion process (1dpf, 2dpf, and 5dpf) and compared to expression in adulthood. Finally, we registered gata2:EGFPbi105 expression to the Zebrafish Brain Browser 6dpf reference brain (ZBB, see Marquart et al., 2015, 2017; Tabor et al., 2019), to allow comparison of this expression pattern with anatomical data already in ZBB
The Iowa Homemaker vol.3, no.8
Table of Contents
The Goal of Home Management Courses at Iowa State by Ruth M. Lindquist, page 3
Home Economics Venture Upon “India’s Coral Strand” by Marcia E. Turner, page 4
The Bell Recipe File by Opal Wind, page 4
Carving the Turkey by Viola M. Bell, page 5
An Interview With Scottish Hockey Coach by Lucile Barta, page 5
Two and One-half Miles Saved a Day by Grata Thorne, page 6
Cranberries for Thanksgiving by Katherine Goeppinger, page 7
Who is Responsible for the Child - by “A Bachelor”, page 8
The Evolution of Home Economics at Iowa State by Ruth Elaine Wilson, page 9
Why is a Mulligan? by “Joe Baggs”, page 10
Turning the Corners Up by Laura E. Bublitz, page 10
The Sport of Amateur Housekeeping by Anna Jacobson, page 11
Who’s There and Where by Helen I. Putnam, page 12
Dressing the Homemaker by Margaret Dix, page 1
Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.
BACKGROUND: Improving the health of school-aged children can yield substantial benefits for cognitive development and educational achievement. However, there is limited experimental evidence of the benefits of alternative school-based malaria interventions or how the impacts of interventions vary according to intensity of malaria transmission. We investigated the effect of intermittent screening and treatment (IST) for malaria on the health and education of school children in an area of low to moderate malaria transmission. METHODS AND FINDINGS: A cluster randomised trial was implemented with 5,233 children in 101 government primary schools on the south coast of Kenya in 2010-2012. The intervention was delivered to children randomly selected from classes 1 and 5 who were followed up for 24 months. Once a school term, children were screened by public health workers using malaria rapid diagnostic tests (RDTs), and children (with or without malaria symptoms) found to be RDT-positive were treated with a six dose regimen of artemether-lumefantrine (AL). Given the nature of the intervention, the trial was not blinded. The primary outcomes were anaemia and sustained attention. Secondary outcomes were malaria parasitaemia and educational achievement. Data were analysed on an intention-to-treat basis. During the intervention period, an average of 88.3% children in intervention schools were screened at each round, of whom 17.5% were RDT-positive. 80.3% of children in the control and 80.2% in the intervention group were followed-up at 24 months. No impact of the malaria IST intervention was observed for prevalence of anaemia at either 12 or 24 months (adjusted risk ratio [Adj.RR]: 1.03, 95% CI 0.93-1.13, p = 0.621 and Adj.RR: 1.00, 95% CI 0.90-1.11, p = 0.953) respectively, or on prevalence of P. falciparum infection or scores of classroom attention. No effect of IST was observed on educational achievement in the older class, but an apparent negative effect was seen on spelling scores in the younger class at 9 and 24 months and on arithmetic scores at 24 months. CONCLUSION: In this setting in Kenya, IST as implemented in this study is not effective in improving the health or education of school children. Possible reasons for the absence of an impact are the marked geographical heterogeneity in transmission, the rapid rate of reinfection following AL treatment, the variable reliability of RDTs, and the relative contribution of malaria to the aetiology of anaemia in this setting. TRIAL REGISTRATION: www.ClinicalTrials.gov NCT00878007
Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence:a population attributable fraction analysis using published epidemiological data
Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England:a mathematical modelling framework
Interrupting transmission of soil-transmitted helminths : a study protocol for cluster randomised trials evaluating alternative treatment strategies and delivery systems in Kenya
Introduction:
In recent years, an unprecedented emphasis has been given to the control of neglected tropical diseases, including soil-transmitted helminths (STHs). The mainstay of STH control is school-based deworming (SBD), but mathematical modelling has shown that in all but very low transmission settings, SBD is unlikely to interrupt transmission, and that new treatment strategies are required. This study seeks to answer the question: is it possible to interrupt the transmission of STH, and, if so, what is the most costeffective treatment strategy and delivery system to achieve this goal?
Methods and analysis:
Two cluster randomised trials are being implemented in contrasting settings in Kenya. The interventions are annual mass anthelmintic treatment delivered to preschool- and school-aged children, as part of a national SBD programme, or to entire communities, delivered by community health workers. Allocation to study group is by cluster, using predefined units used in public health provision—termed community units (CUs). CUs are randomised to one of three groups: receiving either (1) annual SBD; (2) annual community-based deworming (CBD); or (3) biannual CBD. The primary outcome measure is the prevalence of hookworm infection, assessed by four cross-sectional surveys. Secondary outcomes are prevalence of Ascaris lumbricoides and Trichuris trichiura, intensity of species infections and treatment coverage. Costs and cost-effectiveness will be evaluated. Among a random subsample of participants, worm burden and proportion of unfertilised eggs will be assessed longitudinally. A nested process evaluation, using semistructured interviews, focus group discussions and a stakeholder analysis, will investigate the community acceptability, feasibility and scale-up of each delivery system.
Ethics and dissemination:
Study protocols have been reviewed and approved by the ethics committees of the Kenya Medical Research Institute and National Ethics Review Committee, and London School of Hygiene and Tropical Medicine. The study has a dedicated web site.
Trial registration number: NCT0239777
The cosmic ray positron excess and neutralino dark matter
Using a new instrument, the HEAT collaboration has confirmed the excess of
cosmic ray positrons that they first detected in 1994. We explore the
possibility that this excess is due to the annihilation of neutralino dark
matter in the galactic halo. We confirm that neutralino annihilation can
produce enough positrons to make up the measured excess only if there is an
additional enhancement to the signal. We quantify the `boost factor' that is
required in the signal for various models in the Minimal Supersymmetric
Standard Model parameter space, and study the dependence on various parameters.
We find models with a boost factor greater than 30. Such an enhancement in the
signal could arise if we live in a clumpy halo. We discuss what part of
supersymmetric parameter space is favored (in that it gives the largest
positron signal), and the consequences for other direct and indirect searches
of supersymmetric dark matter.Comment: 11 pages, 6 figures, matches published version (PRD
- …